Robo1-specific CAR-NK Immunotherapy Enhances Efficacy of 125I Seed Brachytherapy in an Orthotopic Mouse Model of Human Pancreatic Carcinoma
Authors:
Open Access
- 8 November 2019
- journal article
- research article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 39 (11) , 5919-5925
Abstract
Background/Aim: The aim of the current study was to investigate the synergistic efficacy of Robo1 bichimeric antigen receptor-natural killer cell (BiCAR-NK) immunotherapy and 125I seed brachytherapy in an orthotopic pancreatic cancer mouse model. Materials and Methods: The orthotopic pancreatic tumor model was established with human pancreatic cancer BxPC-3 cells expressing red fluorescent protein. The mice were treated with 125I seed implantation alone or the combination of 125I seeds with Robo1-specific CAR-NK cells. To assess tumor inhibition, in vivo fluorescence imaging was conducted. 7 Tesla magnetic resonance (7T-MR) scanning was applied to measure the changes in the metabolic profiles of tumor tissues. Results: Tumor size was significantly reduced in the 125I and 125I +CAR-NK treated group compared to the untreated group (p125I seed +CAR-NK treated group showed significantly higher tumor reduction than 125I seed treatment alone (p125I +BiCAR-NK treated group had a significantly higher grey scale value than the tumors from the untreated control and the group treated with 125I seed alone (p125I seed brachytherapy in an orthotopic pancreatic cancer mouse model.Keywords
This publication has 27 references indexed in Scilit:
- Current treatment options of T cell-associated immunotherapy in multiple myelomaClinical and Experimental Medicine, 2017
- Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeuticsArchives of Pharmacal Research, 2016
- Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapyMedical Oncology, 2014
- Treatment of patients with advanced cancer with the natural killer cell line NK-92Cytotherapy, 2013
- Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancerEuropean Radiology, 2010
- Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migrationAngiogenesis, 2008
- Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activityCancer Cell, 2003
- NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signalsHuman Immunology, 2000
- Roundabout Controls Axon Crossing of the CNS Midline and Defines a Novel Subfamily of Evolutionarily Conserved Guidance ReceptorsCell, 1998
- Interstitial brachytherapy for pancreatic cancer: Report of seven cases treated with 125 I and a review of the literatureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991